Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 196.80 |
| Open | 196.20 |
| Bid | 196.04 x 100 |
| Ask | 196.43 x 100 |
| Day's range | 195.06 - 197.73 |
| 52-week range | 195.06 - 319.76 |
| Volume | |
| Avg. volume | 1,181,716 |
| Market cap | 28.515B |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 24.61 |
| EPS (TTM) | 7.97 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 300.70 |
GuruFocus.comBiogen Is Suffering From Doubts About the Future
A closer look at one of the leaders in the global multiple sclerosis therapeutics market
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?
The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?
ZacksBiogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know
In the closing of the recent trading day, Biogen Inc. (BIIB) stood at $214.83, denoting a -0.37% change from the preceding trading day.
© 2024 Yahoo. All rights reserved.